@adamfeuersteinJun 1, 2026 · 10:29 PM

On $FULC, excruciating to see one setback after another in sickle cell disease.

@adamfeuersteinJun 1, 2026 · 8:27 PM

$FULC ouch https://t.co/BeaeJj0hO8

@adamfeuersteinDec 8, 2025 · 9:06 PM

$2 billion of stock being offered tonight, collectively, from $GPCR $DYN $VERA $FULC $WVE $KYMR and it's only 4:06 pm.

@adamfeuersteinDec 7, 2025 · 5:28 PM

Fulcrum $FULC study suggests improved efficacy for higher dose sickle cell pill https://t.co/EJWDEJv48o via @Jasonmmast #ASH25

@adamfeuersteinDec 4, 2025 · 4:04 PM

What to expect at the #ASH25 meeting, and some thoughts on the FDA’s Richard Pazdur https://t.co/2Upwf0Oh9M $TERN $INCY $ACLX $FULC

@adamfeuersteinNov 19, 2025 · 2:50 PM

$FULC is the next sickle cell study readout. Higher dose by end of year. Here's what it showed earlier this year: https://t.co/lO8T42eJ1g

@adamfeuersteinJul 29, 2025 · 11:18 AM

Fulcrum $FULC study results suggest a pill can treat sickle cell disease But experts caution the drug’s effect was modest and more data will be need to prove patient benefit https://t.co/lO8T42eJ1g via @statnews